CN106138480A - The medicine of a kind of enhancing immunity or health food - Google Patents

The medicine of a kind of enhancing immunity or health food Download PDF

Info

Publication number
CN106138480A
CN106138480A CN201510132359.9A CN201510132359A CN106138480A CN 106138480 A CN106138480 A CN 106138480A CN 201510132359 A CN201510132359 A CN 201510132359A CN 106138480 A CN106138480 A CN 106138480A
Authority
CN
China
Prior art keywords
vitis viniferae
medicine
enhancing immunity
viniferae extract
health food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510132359.9A
Other languages
Chinese (zh)
Inventor
况代武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yantai Baobei Biotechnology Co Ltd
Original Assignee
Yantai Baobei Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yantai Baobei Biotechnology Co Ltd filed Critical Yantai Baobei Biotechnology Co Ltd
Priority to CN201510132359.9A priority Critical patent/CN106138480A/en
Publication of CN106138480A publication Critical patent/CN106138480A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to medicine or the health food of a kind of enhancing immunity.It is characterized in that containing functional component: resveratrol, procyanidin, vitamin C.Pharmacological research shows that it has good enhancing immunity effect.

Description

The medicine of a kind of enhancing immunity or health food
Technical field
The present invention relates to field of medicaments, be specifically related to a kind of medicine with enhancing immunity effect or health food.
Background technology
Society dog-eat-dog survival pressure sharply increases, and the pressure of work, erratic diet, too fast rhythm of life are all threaten health.Subhealth state is the most just being popular in many people, improves autoimmunity extremely urgent.This just makes us in the face of an important problem: the most safely and effectively enhancing immunity, it is ensured that the health of health.
Summary of the invention
It is an object of the invention to provide medicine or the health food of a kind of safely and effectively enhancing immunity.
The medicine of enhancing immunity of the present invention or health food, mainly contain following raw material: Pericarpium Vitis viniferae extract, Semen Vitis viniferae extract, vitamin C.
The medicine of enhancing immunity of the present invention or health food, mainly contain following functional component: resveratrol, procyanidin, vitamin C.
Wherein, resveratrol is the effective ingredient of Pericarpium Vitis viniferae extract in Angiospermae, Dicotyledoneae, Fructus Vitis viniferae mesh, Vitaceae, Vitis, Fructus Vitis viniferae, has antioxidation, removes free radical, protection cardiovascular, the effect such as anticancer.Resveratrol is a kind of natural antioxidant; blood viscosity can be reduced; the suppression improper cohesion of platelet and vasodilation, keep unblocked blood flowing, to cerebral embolism; the protected effect of myocardial ischemia; prevention myocardial infarction, overweight people can be risen one control and antiobesity action, can the generation of prophylaxis of cancer and development, there is atherosclerosis and coronary heart disease; ischemic heart desease, the preventive and therapeutic effect of hyperlipidemia.The effect of suppression tumor also has estrogen-like effects, can be used for treating the diseases such as breast carcinoma.The cardiac output decline causing burn or hemorrhagic shock has efficient recovery effect.
Procyanidin is Semen Vitis viniferae extract, the effective ingredient of Pericarpium Vitis viniferae extract in Angiospermae, Dicotyledoneae, Fructus Vitis viniferae mesh, Vitaceae, Vitis, Fructus Vitis viniferae, it it is the most potent free radical scavenger found so far, procyanidin (Semen Vitis viniferae extract) is a kind of new and effective antioxidant, has the strongest activity in vivo.It is demonstrated experimentally that the free radical resisting oxidability of OPC is 50 times of vitamin E, ascorbic 20 times, and absorb the most completely, and it being administered orally and i.e. can reach the highest haemoconcentration in 20 minutes, metabolic half life is for 7 hours.
Vitamin C is antibody and collagen formation, tissue repairing (includes some redox), phenylalanine, tyrosine, the metabolism of folic acid, ferrum, the utilization of carbohydrate, fat, the synthesis of protein, maintain immunologic function, hydroxylation and hydroxytryptamine, keep the complete of blood vessel, promote that the institutes such as nonheme iron absorption are required.
The present invention selects resveratrol oxidation and removing free radicals, procyanidin antioxidation, and vitamin C maintains immunologic function.All medicines share, multinomial compatibility common enhancing human body immunity power.Fundamentally increase immunity, strengthening body resistance.
This medicine or the optimised process of health food:
Weigh the raw material of following weight proportion: Pericarpium Vitis viniferae extract 3.52 parts, Semen Vitis viniferae extract 5 parts, Catergen .5 part, add magnesium stearate 0.25 weight portion, starch 5 weight portion, microcrystalline Cellulose 1.55 weight portion, mixing, capsule fill, make capsule.
This medicine or health food have good enhancing immunity effect.
Relevant pharmacological experimental data
1, laboratory animal
Experiment cleaning grade female ICR white mice, body weight (20 ± 2) g.Detection environmental condition, temperature range 20 ~ 25 DEG C, relative humidity 40% ~ 70%.In Animal House environment, 3d is adapted to before mouse experiment.
2, test method
2.1, experiment packet and cycle each pilot project all set up experimental group and the negative control group of various dose, often group 10, wherein experimental group dosage is respectively by human body recommended dose 1.6g/d(60kg*d) 5 times, 10 times, 30 times of designs low dose group (0.13g/kg), middle dosage group (0.27g/kg), high dose group (0.80g/kg) all experimental grouies per os (gavage) give the sample of various dose, gavage volume is 0.1ml/10g body weight, once/d, counts 30d;Negative group gives the normal saline with same volume.
2.2, experimental technique and interpretation of result
2.2.1, splenocyte Cell transformation test: experiment the 30th day, every mice is aseptic took spleen, is placed in and fills in appropriate aseptic Hanks liquid plate, is ground by spleen gently with tweezers, make single cell suspension.Filter through 200 eye mesh screens, or with 4 layers of gauze, spleen is ground, wash 2 times with Hanks liquid, be centrifuged 10min(1000r/min every time).Then, by cell suspension in 1ml complete culture solution, with platform phenol indigo plant dyeing counting viable count (should be more than 95%), adjusting cell concentration is 3 × 106/ml.Cell suspension point holes being added in 24 well culture plates, every hole 1ml, a hole adds 75 μ l ConA liquid (being equivalent to 7.5 μ g/ml), and 5% CO2, as comparison, is put in another hole, cultivates 72h in 37 DEG C of CO2 incubators.Cultivation terminates front 4h, and every hole sucks supernatant 0.7ml gently, adds the 0.7ml RPMI1640 culture fluid without calf serum, is simultaneously introduced MTT(5mg/ml) 50 μ l/ holes, continue to cultivate 4h.After cultivation terminates, every hole adds 1ml acid isopropyl alcohol, piping and druming mixing, makes purple crystal be completely dissolved.Then solution is moved in cuvette, measure optical density value OD value with 721 spectrophotometers at wavelength 570nm.Finally deduct the optical density value in ConA hole by the optical density value adding ConA hole and represent the multiplication capacity of lymphocyte.
2.2.2, mice serum hemolysin test: at experiment the 25th day, every Mus abdomen injection 0.2ml2%(V/V) hematocrit sheep red blood cell (SRBC) (SRBC) suspension, carry out immunity.After 5d, take blood and be centrifuged, collect serum, with normal saline by serum doubling dilution, 37 DEG C of incubation 3h, observe hemagglutination degree, calculating antibody product.
2.2.3 30min before, macrophage phagocytic chicken red blood cell experimental animal is put to death, every Mus abdomen injection 1.0ml20%(V/V) chicken erythrocyte suspension, place after death reinjects 2ml normal saline, take abdominal cavity drop sheet, 37 DEG C of incubation 30min, fix, dyeing, microscopy, counts 100 macrophages, calculates phagocytic rate and phagocytic index.
2.2.4, internal organs/body weight ratio put to death animal, take its thymus and spleen, weigh, calculate thymus/body weight and spleen/body weight ratio.
2.2.5, the multiple samples of experimental data statistics compare employing variance analysis process data;Multisample compares employing q inspection two-by-two.P < 0.05 has statistical significance for difference.
3, result
3.1, the impact of the mice spleen lymphocytes proliferation ability that ConA is induced by the lymphopoiesis ability present invention, is shown in Table 1.Experimental group compares with negative control group, and three dosage groups all can significantly improve the multiplication capacity of splenocyte.
The impact (g/kg) of the mice spleen lymphocytes proliferation ability that ConA is induced by table 1 present invention
Compared with negative control group, P < 0.05
The 3.2 serum hemolysin present invention impact on mice serum hemolysin, is shown in Table 2.Experimental group compares with negative control group, and three dosage groups all can significantly improve mice serum hemolytic antibody product level.
Table 2 present invention impact (g/kg) on the impact of mice serum hemolysin
Compared with negative control group, P < 0.05
3.3, the peritoneal macrophage phagocytosis chicken red blood cell present invention impact on Turnover of Mouse Peritoneal Macrophages phagocytosis chicken red blood cell, is shown in Table 3.Experimental group compares with negative control group, and three dosage groups all can improve the phagocytic rate of spleen Turnover of Mouse Peritoneal Macrophages phagocytosis chicken red blood cell.
Table 3 present invention impact [g/kg(%)] on Turnover of Mouse Peritoneal Macrophages phagocytosis chicken red blood cell
Compared with negative control group, P < 0.05
3.4, internal organs/proportion ratio present invention impact on mice organs/body weight ratio, is shown in Table 4.Three dosage group mouse thymus/body weight ratios and spleen/body weight ratio and negative control group compare, and there was no significant difference (P > 0.05)
Table 4 present invention impact (g/kg, mg/g) on mice organs/proportion ratio
Compared with negative control group, P > 0.05
1, discuss
According to enhancing immunity experimental result decision rule in " function of health food assessment process and the method for inspection ": " enhancing immunity function judges: in cellular immune function, humoral immune function, mononuclear phagocyte function, any two aspect results positives of four aspects of NK cytoactive, can determine that this given the test agent has enhancing immunity function." the study show that: the present invention is on mouse thymus/body weight ratio and spleen/body weight ratio without impact, and the present invention can improve the multiplication capacity of the mouse spleen lymphocyte of ConA induction, can improve mice serum hemolytic antibody product level;The phagocytic rate of Turnover of Mouse Peritoneal Macrophages phagocytosis chicken red blood cell can be improved, illustrate that the present invention has the effect of enhancing immunity.
Detailed description of the invention
Embodiment 1 :
Weigh Pericarpium Vitis viniferae extract 35.7 parts, Semen Vitis viniferae extract 5 parts, vitamin C 2.5 parts add magnesium stearate 0.25 weight portion, starch 5 weight portion, microcrystalline Cellulose 1.55 weight portion, mixing, and capsule fill is packaged into bottle.
Embodiment 2 :
Weigh Pericarpium Vitis viniferae extract 36 parts, Semen Vitis viniferae extract 4 parts, vitamin C 3 parts add magnesium stearate 0.2 weight portion, starch 6 weight portion, microcrystalline Cellulose 1.5 weight portion, mixing, and capsule fill is packaged into bottle.
Embodiment 3 :
Weigh Pericarpium Vitis viniferae extract 36 parts, Semen Vitis viniferae extract 4 parts, vitamin C 3 parts add magnesium stearate 0.25 weight portion, starch 6 weight portion, microcrystalline Cellulose 1.5 weight portion, and mixing is pelletized, and 75 DEG C are dried, and granulate is packaged into bag.
Embodiment 4 :
Weigh Pericarpium Vitis viniferae extract 10 parts, Semen Vitis viniferae extract 1 part, vitamin C 1 part add magnesium stearate 0.25 weight portion, starch 7 weight portion, microcrystalline Cellulose 1.0 weight portion, and mixing is pelletized, and 75 DEG C are dried, and granulate is packaged into bag.
Embodiment 5 :
Weigh Pericarpium Vitis viniferae extract 36 parts, Semen Vitis viniferae extract 4 parts, vitamin C 3 parts add magnesium stearate 0.25 weight portion, starch 4 weight portion, microcrystalline Cellulose 2 weight portion, mixing, and tabletting is aluminum-plastic packaged, is packaged into box.
Embodiment 6 :
Weigh Pericarpium Vitis viniferae extract 34 parts, Semen Vitis viniferae extract 4 parts, vitamin C 3 parts add magnesium stearate 0.25 weight portion, starch 5 weight portion, microcrystalline Cellulose 1 weight portion, and mixing is pelletized, and 75 DEG C are dried, granulate, and capsule fill is aluminum-plastic packaged, is packaged into box.

Claims (6)

1. a medicine with enhancing immunity function or health food, it is characterised in that containing active ingredient: resveratrol, procyanidin, vitamin C.
The medicine with enhancing immunity function the most according to claim 1 or health food, it is characterised in that optimal active ingredient contained by it: Semen Vitis viniferae extract, Pericarpium Vitis viniferae extract, vitamin C.
The medicine with enhancing immunity function the most according to claim 1 or health food, it is characterised in that its weight proportion containing each composition is: resveratrol 1 ~ 40 part, procyanidin 5 ~ 40 parts, vitamin C 1 ~ 10 part.
The medicine with enhancing immunity function the most according to claim 3 or health food, it is characterised in that its weight proportion containing each composition is: Pericarpium Vitis viniferae extract 1 ~ 40 part, Semen Vitis viniferae extract 5 ~ 40 parts, vitamin C 1 ~ 10 part.
The medicine with enhancing immunity function the most according to claim 4 or health food, it is characterised in that its optimum weight proportioning containing each composition is: Pericarpium Vitis viniferae extract 35.7 parts, Semen Vitis viniferae extract 5 parts, Catergen .5 part.
The medicine with enhancing immunity function the most according to claim 5 or health food, it is characterized in that its preparation technology is: weigh the Pericarpium Vitis viniferae extract of above-mentioned weight proportion, Semen Vitis viniferae extract, vitamin C add magnesium stearate 0.25 weight portion, starch 5 weight portion, microcrystalline Cellulose 1.55 weight portion, mixing, capsule fill, makes capsule.
CN201510132359.9A 2015-03-25 2015-03-25 The medicine of a kind of enhancing immunity or health food Pending CN106138480A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510132359.9A CN106138480A (en) 2015-03-25 2015-03-25 The medicine of a kind of enhancing immunity or health food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510132359.9A CN106138480A (en) 2015-03-25 2015-03-25 The medicine of a kind of enhancing immunity or health food

Publications (1)

Publication Number Publication Date
CN106138480A true CN106138480A (en) 2016-11-23

Family

ID=57339003

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510132359.9A Pending CN106138480A (en) 2015-03-25 2015-03-25 The medicine of a kind of enhancing immunity or health food

Country Status (1)

Country Link
CN (1) CN106138480A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103704720A (en) * 2013-12-20 2014-04-09 林元藻 Anti-aging healthcare food for middle aged and elderly people

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103704720A (en) * 2013-12-20 2014-04-09 林元藻 Anti-aging healthcare food for middle aged and elderly people

Similar Documents

Publication Publication Date Title
CN105363023A (en) Composition with effects of protecting joints and increasing bone mineral density and preparation method of composition
CN105394749B (en) A kind of Ricipe for health care food and preparation method and application containing astaxanthin
CN103169737B (en) Composite of Antrodia camphorata entity and shell-broken ganoderma lucidum spore powder and application thereof in immune adjustment
CN104799286B (en) Composition for improving immunity and preparation method of composition
CN105031301A (en) Anti-tumor traditional Chinese medicine composition and preparation method thereof
CN103976359A (en) Food nutrition enriched composition and application thereof as well as healthcare food and preparation method thereof
CN110178906A (en) A kind of strengthen immunity improves the decline of chemotherapy blood picture, liver and the impaired food compositions and its preparation process of gastrointestinal tract
WO2012167656A1 (en) Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof
CN106983821B (en) A kind of pharmaceutical composition of strengthen immunity and preparation method thereof, preparation and application
CN108813610A (en) A kind of saussurea involucrata composition and its application for improving immunity
CN107669817A (en) A kind of preparation method, product and its application of the anti-enteritis micro-capsule of oil-tea camellia husks
CN102114067A (en) Compound oviductus ranae granules and application thereof
CN104560378A (en) Blueberry seed oil as well as preparation method and application thereof
CN103735621B (en) A kind of Chinese medicine composition with blood fat reducing and enhancing immunity effect
CN104288164B (en) Pharmaceutical composition for preventing acute alcoholic liver injury
CN103393710B (en) A kind of Preparation method and use of fermented Cordyceps powder polysaccharides compound
CN103829254A (en) Application of proanthocyanidins in preparing diet food or drug
CN106138480A (en) The medicine of a kind of enhancing immunity or health food
AU2012325600B2 (en) Pharmaceutical composition regulating blood fat and preparation process thereof
CN106176787A (en) The application in preparing anticancer or antitumor drug of phillyrin, phillyrin derivant, phillyrin and phillygenol compositions and medicine
CN102727867B (en) Antineoplastic pharmaceutical composition and application thereof, kit and package
CN106177227A (en) A kind of compositions containing coenzyme Q10 strengthening body immunity
CN102397281A (en) Ginsenoside composition for treating cardiovascular and cerebrovascular diseases
CN101361799B (en) Composition containing brown alga polysaccharide sulfuric ester and schisandra chinensis and use thereof
CN103784492A (en) Pratia begonafolia (Wall) Lindl. or P. nummularia (Lam.)A.Br.et Aschers extract with antitumor effect and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161123